Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rheosorbilact vs Ringer's Lactate in Peritonitis
NCT03771170Phase 4Completed
- Sponsor
- YURiA-PHARM
- Start
- Jan 2018
- Primary completion
- Dec 2019
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 4
01
Overview
Phase 4, randomised, single-blind trial of rheosorbilact in peritonitis (2 arms), sponsored by YURiA-PHARM. Primary endpoint: Change in total SOFA score vs. baseline at Day 3. Started Jan 2018; status: completed.
02
Drugs
rheosorbilact
03
Conditions
peritonitis
Beyond the preview
Go deeper on NCT03771170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771170.